BACKGROUND: Our objective was to analyze the effects of age, gender, and the use of oral contraceptives (OCs) on coagulation using thrombelastography (TEG), a single test to analyze both plasma coagulation factors and cellular elements in whole blood. METHODS: TEG variables were measured in native whole blood and in recalcified citrated blood from 120 healthy adults (60 men and 60 women) with various ages and in an additional 29 healthy women using OCs. RESULTS: We observed hypercoagulability in women compared with men and in women using OCs compared with age-matched nonusers. Moreover, we found hypercoagulability with aging. Using the method of Bland and Altman (Lancet 1986;1:307-10), we demonstrated no correlation between TEG measurements in native and recalcified citrated blood. CONCLUSIONS: Aging, female gender, use of OCs, and low-normal hematocrit levels have significant procoagulant effects. TEG measurements in native and recalcified citrated blood are not interchangeable, as indicated by differences between the 2 measurements ranging from 20% in maximal amplitude to 246% in clotting time. Furthermore, the limits of agreement strongly exceeded clinical acceptability to conclude interchangeability.
BACKGROUND: Our objective was to analyze the effects of age, gender, and the use of oral contraceptives (OCs) on coagulation using thrombelastography (TEG), a single test to analyze both plasma coagulation factors and cellular elements in whole blood. METHODS: TEG variables were measured in native whole blood and in recalcified citrated blood from 120 healthy adults (60 men and 60 women) with various ages and in an additional 29 healthy women using OCs. RESULTS: We observed hypercoagulability in women compared with men and in women using OCs compared with age-matched nonusers. Moreover, we found hypercoagulability with aging. Using the method of Bland and Altman (Lancet 1986;1:307-10), we demonstrated no correlation between TEG measurements in native and recalcified citrated blood. CONCLUSIONS: Aging, female gender, use of OCs, and low-normal hematocrit levels have significant procoagulant effects. TEG measurements in native and recalcified citrated blood are not interchangeable, as indicated by differences between the 2 measurements ranging from 20% in maximal amplitude to 246% in clotting time. Furthermore, the limits of agreement strongly exceeded clinical acceptability to conclude interchangeability.
Authors: Marcel Adler; Sandra Ivic; Nicolas S Bodmer; Hugo Ten Cate; Lucas M Bachmann; Walter A Wuillemin; Michael Nagler Journal: Transfus Med Hemother Date: 2017-03-08 Impact factor: 3.747
Authors: Julia R Coleman; Ernest E Moore; Jason M Samuels; Mitchell J Cohen; Angela Sauaia; Joshua J Sumislawski; Arsen Ghasabyan; James G Chandler; Anirban Banerjee; Christopher C Silliman; Erik D Peltz Journal: J Am Coll Surg Date: 2019-01-21 Impact factor: 6.113
Authors: Jason Samuels; Peter J Lawson; Alexander P Morton; Hunter B Moore; Kirk C Hansen; Angela Sauaia; Jonathan A Schoen Journal: Surg Obes Relat Dis Date: 2019-04-10 Impact factor: 4.734
Authors: Julia R Coleman; Ernest E Moore; Marguerite R Kelher; Jason M Samuels; Mitchell J Cohen; Angela Sauaia; Anirban Banerjee; Christopher C Silliman; Erik D Peltz Journal: J Trauma Acute Care Surg Date: 2019-11 Impact factor: 3.313
Authors: Andrea Elliott; Jeremy Wetzel; Tiffany Roper; Evan Pivalizza; James McCarthy; Cristina Wallace; Mary Jane Hess; Hui Peng; Mohammad H Rahbar; Navdeep Sangha; James C Grotta Journal: Int J Stroke Date: 2012-09-27 Impact factor: 5.266
Authors: Joshua B Brown; Mitchell J Cohen; Joseph P Minei; Ronald V Maier; Michael A West; Timothy R Billiar; Andrew B Peitzman; Ernest E Moore; Joseph Cuschieri; Jason L Sperry Journal: J Trauma Acute Care Surg Date: 2012-12 Impact factor: 3.313